New Laser-Ointment combo could replace surgery for skin cancer
NCT ID NCT07010692
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 38 times
Summary
This study tests whether using special lasers followed by a medicated ointment can effectively treat two common types of skin cancer: squamous cell carcinoma and basal cell carcinoma. About 100 adults with biopsy-confirmed skin cancer will receive the laser treatment and then apply the ointment at home for five nights. The goal is to clear the cancer while avoiding invasive surgery, leading to better cosmetic results and a treatment option suitable for many people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bruce Robinson, MD
RECRUITINGNew York, New York, 10022, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.